Free Trial

LENSAR (LNSR) Stock Price, News & Analysis

LENSAR logo
$12.35 +0.07 (+0.57%)
Closing price 04:00 PM Eastern
Extended Trading
$12.35 0.00 (0.00%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About LENSAR Stock (NASDAQ:LNSR)

Key Stats

Today's Range
$12.10
$12.49
50-Day Range
$12.15
$13.32
52-Week Range
$3.80
$17.31
Volume
62,865 shs
Average Volume
58,464 shs
Market Capitalization
$147.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00
Consensus Rating
Hold

Company Overview

LENSAR Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
22nd Percentile Overall Score

LNSR MarketRank™: 

LENSAR scored higher than 22% of companies evaluated by MarketBeat, and ranked 870th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LENSAR has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    LENSAR has received no research coverage in the past 90 days.

  • Read more about LENSAR's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LENSAR is -2.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LENSAR is -2.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    LENSAR has a P/B Ratio of 29.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about LENSAR's valuation and earnings.
  • Percentage of Shares Shorted

    6.46% of the float of LENSAR has been sold short.
  • Short Interest Ratio / Days to Cover

    LENSAR has a short interest ratio ("days to cover") of 6.3.
  • Change versus previous month

    Short interest in LENSAR has recently increased by 17.77%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    LENSAR does not currently pay a dividend.

  • Dividend Growth

    LENSAR does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.46% of the float of LENSAR has been sold short.
  • Short Interest Ratio / Days to Cover

    LENSAR has a short interest ratio ("days to cover") of 6.3.
  • Change versus previous month

    Short interest in LENSAR has recently increased by 17.77%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    LENSAR has a news sentiment score of 1.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.12 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for LENSAR this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, LENSAR insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    66.00% of the stock of LENSAR is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    40.15% of the stock of LENSAR is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LENSAR's insider trading history.
Receive LNSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LNSR Stock News Headlines

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Lensar (LNSR) Q2 Revenue Rises 10%
I’d rather trade news like this than gamble on hype
Real traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal just triggered a key alert in Tim Sykes’ system… and the setup looks strong.tc pixel
See More Headlines

LNSR Stock Analysis - Frequently Asked Questions

LENSAR's stock was trading at $8.94 at the start of the year. Since then, LNSR stock has increased by 38.1% and is now trading at $12.35.

LENSAR, Inc. (NASDAQ:LNSR) released its quarterly earnings results on Thursday, August, 7th. The company reported ($0.15) EPS for the quarter, missing analysts' consensus estimates of ($0.08) by $0.08. The company had revenue of $11.36 million for the quarter, compared to analysts' expectations of $16.55 million. LENSAR had a negative net margin of 84.49% and a negative trailing twelve-month return on equity of 737.30%.

LENSAR's top institutional investors include Brandes Investment Partners LP (4.72%), Groupe la Francaise (2.11%), Geode Capital Management LLC (1.86%) and Credit Industriel ET Commercial (1.43%). Insiders that own company stock include Thomas R Staab II and Gary M Winer.
View institutional ownership trends
.

Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LENSAR investors own include Arch Capital Group (ACGL), Aprea Therapeutics (APRE), Artelo Biosciences (ARTL), AstraZeneca (AZN), Baidu (BIDU), Cidara Therapeutics (CDTX) and Carlyle Group (CG).

Company Calendar

Last Earnings
8/07/2025
Today
9/02/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:LNSR
CIK
1320350
Fax
N/A
Employees
110
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$15.00
Potential Upside/Downside
+21.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$31.40 million
Net Margins
-84.49%
Pretax Margin
-84.49%
Return on Equity
-737.30%
Return on Assets
-72.60%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.52
Quick Ratio
0.88

Sales & Book Value

Annual Sales
$53.49 million
Price / Sales
2.76
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.42 per share
Price / Book
29.40

Miscellaneous

Outstanding Shares
11,940,000
Free Float
4,058,000
Market Cap
$147.46 million
Optionable
Optionable
Beta
0.49
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:LNSR) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners